Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Karen Dubé"'
Autor:
Corey P. Mallett, Xavier Bouhy, Marie-Hélène Joly, Chantal Rhéaume, Guy Boivin, Andrés Pizzorno, Edith Beaulieu, Laurent Kaiser, Arnaud G L'Huillier, Clément Fage, Miguel Retamal, Yacine Abed, Karen Dubé
Publikováno v:
Antiviral Research, Vol. 132 (2016) pp. 6-12
We recently isolated an influenza A(H1N1)pdm09 E119D/H275Y neuraminidase (NA) variant from an immunocompromised patient who received oseltamivir and zanamivir therapies. This variant demonstrated cross resistance to zanamivir, oseltamivir, peramivir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be124877c168ddadcb251ca3a87e58f0
https://doi.org/10.1016/j.antiviral.2016.05.006
https://doi.org/10.1016/j.antiviral.2016.05.006
Autor:
Xavier Bouhy, Karen Dubé, Edith Beaulieu, Yacine Abed, Corey P. Mallett, Marie-Ève Hamelin, Julie Ann, Guy Boivin, Marie-Hélène Joly, Julie Carbonneau
Publikováno v:
Influenza and Other Respiratory Viruses
Viral fitness of a laninamivir-selected influenza A/Brisbane/10/2007-like (H3N2) isolate (LRVp9) containing a 237-amino acid neuraminidase deletion and a P194L hemagglutinin mutation was evaluated in vitro and in ferrets. LRVp9 and the wild-type (WT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96af122a376b8746b6554f653a71a1e
https://doi.org/10.1111/irv.12356
https://doi.org/10.1111/irv.12356
Autor:
Guy Boivin, Karen Dubé, Corey P. Mallett, Marie-Ève Hamelin, Xavier Bouhy, Mariana Baz, Edith Beaulieu
Publikováno v:
Antiviral therapy. 16(5)
Background The H275Y neuraminidase mutation conferring oseltamivir resistance has been reported in several pandemic A/H1N1 (pH1N1) isolates. We sought to evaluate transmission of this mutant virus through the direct contact and the airborne (aerosol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3dbea38e37220fe244ca66f8e6c4e8
https://pubmed.ncbi.nlm.nih.gov/21817200
https://pubmed.ncbi.nlm.nih.gov/21817200
Autor:
Karen, Dubé, Mary-Lynne, Flake
Publikováno v:
The Canadian nurse. 99(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c9f789a8381d317d6b39793913894588
https://pubmed.ncbi.nlm.nih.gov/12630267
https://pubmed.ncbi.nlm.nih.gov/12630267
Publikováno v:
Leukemia Research Reports, Vol 3, Iss 1, Pp 28-31 (2014)
Non-myeloablative allogeneic transplant (NMAT) has a curative potential for patients who are not myeloablative allogeneic transplant (MAT) candidates. We report a phase II trial of a NMAT regimen with cyclophosphamide and fludarabine in 40 patients;
Externí odkaz:
https://doaj.org/article/2c84241ceb7243babc03dc562cf2d1ec